137 related articles for article (PubMed ID: 30101499)
1. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
3. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
Akizue N; Okimoto K; Arai M; Hirotsu Y; Amemiya K; Oura H; Kaneko T; Tokunaga M; Ishikawa K; Ohta Y; Taida T; Saito K; Maruoka D; Matsumura T; Nakagawa T; Nishimura M; Chiba T; Matsushita K; Mochizuki H; Yokosuka O; Omata M; Kato N
Cancer Med; 2021 Jun; 10(11):3545-3555. PubMed ID: 33934524
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence diagnostic system predicts multiple Lugol-voiding lesions in the esophagus and patients at high risk for esophageal squamous cell carcinoma.
Ikenoyama Y; Yoshio T; Tokura J; Naito S; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Katayama N; Tada T; Fujisaki J
Endoscopy; 2021 Nov; 53(11):1105-1113. PubMed ID: 33540446
[TBL] [Abstract][Full Text] [Related]
6. Delineating the extent of esophageal squamous cell carcinoma.
Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
[TBL] [Abstract][Full Text] [Related]
7. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
[TBL] [Abstract][Full Text] [Related]
8. Multiple foci of dilated vessels as a new predictor of metachronous esophageal cancer.
Kawakami Y; Ishihara R; Matsuno K; Waki K; Shichijo S; Yoshii S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Tanaka Y
Dig Endosc; 2024 Apr; 36(4):421-427. PubMed ID: 37553826
[TBL] [Abstract][Full Text] [Related]
9. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
[TBL] [Abstract][Full Text] [Related]
10. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic screening for upper gastrointestinal second primary malignancies in patients with hypopharyngeal squamous cell carcinoma].
Tian JJ; Xu W; Lyu ZH; Ma JK; Cui P; Sa N; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):292-295. PubMed ID: 29747255
[No Abstract] [Full Text] [Related]
12. Retrospective Assessment of the Diagnostic Accuracy of the Depth of Invasion by Narrow Band Imaging Magnifying Endoscopy in Patients with Superficial Esophageal Squamous Cell Carcinoma.
Katada C; Tanabe S; Wada T; Ishido K; Yano T; Furue Y; Kondo Y; Kawanishi N; Yamane S; Watanabe A; Azuma M; Koizumi W
J Gastrointest Cancer; 2019 Jun; 50(2):292-297. PubMed ID: 29435906
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of superficial esophageal squamous cell carcinomas undetectable with narrow-band imaging endoscopy.
Ono S; Dobashi A; Furuhashi H; Koizumi A; Matsui H; Hara Y; Sumiyama K
Gastroenterol Rep (Oxf); 2021 Oct; 9(5):402-407. PubMed ID: 34733525
[TBL] [Abstract][Full Text] [Related]
14. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of magnifying blue laser imaging versus magnifying narrow-band imaging for identifying the depth of invasion of superficial esophageal squamous cell carcinoma.
Ueda T; Dohi O; Naito Y; Yoshida T; Azuma Y; Ishida T; Matsumura S; Kitae H; Takayama S; Mizuno N; Nakano T; Iwai N; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
Dis Esophagus; 2021 Mar; 34(3):. PubMed ID: 32691042
[TBL] [Abstract][Full Text] [Related]
16. Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions.
Chen Z; Dou L; Liu Y; Zhang Y; He S; Xue L; Wang G
Front Oncol; 2021; 11():786015. PubMed ID: 34900740
[TBL] [Abstract][Full Text] [Related]
17. Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients.
Ye YC; Wang YP; Chang TE; Wu PS; Hsin IF; Chen PH; Tai SK; Chu PY; Hou MC; Lu CL
Esophagus; 2024 Apr; 21(2):131-140. PubMed ID: 38194013
[TBL] [Abstract][Full Text] [Related]
18. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
[TBL] [Abstract][Full Text] [Related]
20. The sub-classification of type B2 vessels according to the magnifying endoscopic classification of the Japan Esophageal Society.
Tanaka I; Hirasawa D; Saito H; Matsuda T; Nakahori M; Maeda Y; Okuzono T; Suzuki K; Igarashi K; Nawata Y; Ito S; Unno S; Chonan A
Dig Endosc; 2020 Jan; 32(1):49-55. PubMed ID: 31177563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
